Pre-eclampsia — Efficacy Study of Digibind for Treatment of Severe Preeclampsia
Citation(s)
A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia